Eungdo Kim
Biographic Data
| ID | 8942241 |
|---|---|
| NAME | Eungdo Kim |
| GIVEN NAMES | Eungdo |
| FAMILY NAME | Kim |
| SIGNATURE | KIM E |
| AFFILIATIONS | Eungdo Kim (corresponding author), Department of Biomedical Convergence, Chungbuk National University, Cheongju 28644, South Korea; Department of R&D Planning and Support, Chungbuk National University Hospital, Cheongju 28644, South Korea. |
| ORCID | 0000-0002-2942-6588 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Productivity of the Korean Biopharmaceutical Industry
The biopharmaceutical industry in Korea is considered a key strategic industry following the semiconductor industry. However, success in the biopharmaceutical industry depends on the outcome of research and development processes that require long periods and substantial investment, resulting in a success rate of only around 2.5%–4% for new drug development. Consequently, rational strategic choices, such as determining key capabilities to pursue b…
Impact of the Use of Emerging Technologies on Organisational Knowledge-creation Capability by Task Complexity
In the context of knowledge-based economy, an organisation’s ability to create knowledge is the most important factor in maintaining its competitiveness. Collective intelligence is posited as a paramount methodology not only for the generation of knowledge pertaining to multifaceted issues but also as a fundamental pillar within the framework of organizational knowledge management. The use of emerging technologies is an important strategy for imp…
The Optimal Diversification Strategy in Pharmaceutical Industry
Due to high uncertainty of product development and business environment, firm-level diversification has been regarded as one of the most effective methods in pharmaceutical firms. In previous study, firm-level diversification was discussed by different value chains of market, product, and technology. However, in most cases, the diversification itself was adopted in a simple manner although its property contains different aspects and the results v…
No prominent works on this page.
The Optimal Diversification Strategy in Pharmaceutical Industry
Due to high uncertainty of product development and business environment, firm-level diversification has been regarded as one of the most effective methods in pharmaceutical firms. In previous study, firm-level diversification was discussed by different value chains of market, product, and technology. However, in most cases, the diversification itself was adopted in a simple manner although its property contains different aspects and the results v…
Productivity of the Korean Biopharmaceutical Industry
The biopharmaceutical industry in Korea is considered a key strategic industry following the semiconductor industry. However, success in the biopharmaceutical industry depends on the outcome of research and development processes that require long periods and substantial investment, resulting in a success rate of only around 2.5%–4% for new drug development. Consequently, rational strategic choices, such as determining key capabilities to pursue b…
Impact of the Use of Emerging Technologies on Organisational Knowledge-creation Capability by Task Complexity
In the context of knowledge-based economy, an organisation’s ability to create knowledge is the most important factor in maintaining its competitiveness. Collective intelligence is posited as a paramount methodology not only for the generation of knowledge pertaining to multifaceted issues but also as a fundamental pillar within the framework of organizational knowledge management. The use of emerging technologies is an important strategy for imp…
Business (3 works) · Industrial organization (2 works) · Intellectual Property and Patents (2 works) · Marketing (2 works) · Artificial Intelligence (1 works) · Big data (1 works) · Big Data and Business Intelligence (1 works) · Biopharmaceutical (1 works) · Biotechnology (1 works) · Collective intelligence (1 works)